关注
Dr Beena Negi
Dr Beena Negi
Gargi College
在 gargi.du.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Synthesis and antioxidant activity of thymol and carvacrol based Schiff bases
D Kumar, DS Rawat
Bioorganic & medicinal chemistry letters 23 (3), 641-645, 2013
1722013
Antituberculosis drug research: a critical overview
Beena, DS Rawat
Medicinal research reviews 33 (4), 693-764, 2013
1412013
Conventional and green methods of synthesis of silver nanoparticles and their antimicrobial properties
R Vishwanath, B Negi
Current Research in Green and Sustainable Chemistry 4, 100205, 2021
1272021
Synthesis of novel 1, 2, 3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation
D Kumar, G Khare, S Kidwai, AK Tyagi, R Singh, DS Rawat
European journal of medicinal chemistry 81, 301-313, 2014
972014
Synthesis and antibacterial activity evaluation of metronidazole–triazole conjugates
N Kumar, RK Rohilla, N Roy, DS Rawat
Bioorganic & medicinal chemistry letters 19 (5), 1396-1398, 2009
922009
Marine peptides as anticancer agents: A remedy to mankind by nature
B Negi, D Kumar, D S Rawat
Current Protein and Peptide Science 18 (9), 885-904, 2017
602017
Synthesis, antimalarial activity and cytotoxicity of substituted 3,6-diphenyl-[1,2,4,5]tetraoxanes.
N Kumar, SI Khan, Beena, G Rajalakshmi, P Kumaradhas, DS Rawat
Bioorg. Med. Chem. 17, 5632–5638, 2009
552009
Anti-methicillin resistant Staphylococcus aureus activity, synergism with oxacillin and molecular docking studies of metronidazole-triazole hybrids
B Negi, D Kumar, W Kumbukgolla, S Jayaweera, P Ponnan, R Singh, ...
European Journal of Medicinal Chemistry 115, 426-437, 2016
532016
The anti-tuberculosis agents under development and the challenges ahead
D Kumar, B Negi, DS Rawat
Future medicinal chemistry 7 (15), 1981-2003, 2015
462015
Novel isoniazid-amidoether derivatives: Synthesis, characterization and antimycobacterial activity evaluation.
D Kumar, G Khare, B Negi, S Kidwai, AK Tyagi, R Singh, DS Rawat
Med. Chem. Commun. 6, 131, 2015
362015
In vitro antiamoebic activity evaluation and docking studies of metronidazole–triazole hybrids
B Negi, KK Raj, SM Siddiqui, D Ramachandran, A Azam, DS Rawat
ChemMedChem 9 (11), 2439-2444, 2014
242014
Synthesis, antiamoebic activity and docking studies of metronidazole-triazole-styryl hybrids
B Negi, P Poonan, MF Ansari, D Kumar, S Aggarwal, R Singh, A Azam, ...
European Journal of Medicinal Chemistry 150, 633-641, 2018
222018
Synthesis and antitubercular activity evaluation of novel unsymmetrical cyclohexane-1,2-diamine derivatives
Beena, S Joshi, N Kumar, S Kidwai, R Singh, DS Rawat
Arch. Pharm. Chem. Life Sci. 345, 896–901, 2012
162012
Antibacterial activity of adamantyl substituted cyclohexane diamine derivatives against methicillin resistant Staphylococcus aureus and Mycobacterium tuberculosis
D Kumar, W Kumbukgolla, S Jayaweera, MA Bailey, T Alling, J Ollinger, ...
RSC advances 4 (23), 11962-11966, 2014
132014
Synthesis and antituberculosis activity evaluation of cyclohexane-1, 2-diamine derivatives
KD Beena, MA Bailey, T Parish, DS Rawat
Chem. Biol. Interface 4 (1), 23-36, 2014
82014
Antituberculosis activity evaluation of thymol Schiff bases.
B Negi, DS Rawat
Chemistry & Biology Interface 8 (4), 2018
32018
Synthesis, characterization, and antimycobacterial activity of novel thymol-triazole hybrids
B Negi, DS Rawat
Indian J. Heterocycl. Chem 28, 113-123, 2018
32018
Synthesis, in silico pharmacokinetic analysis and anticancer activity evaluation of benzothiazole-triazole hybrids
S Rawat, DS Rawat, B Negi
Indian Journal of Chemistry-Section B (IJC-B) 60 (3), 409-417, 2021
12021
Diverse Pharmacological Activities of 4-Aminoquinoline and its Derivatives
D Kumar, B Negi, DS Rawat
Recent Advances in Pharmaceutical Innovation and Research, 243-292, 2023
2023
Multiple biological activities and docking studies of metronidazole triazole hybrids
B Negi
Indian Journal of Nuclear Medicine 32 (suppl.), 32, 2017
2017
系统目前无法执行此操作,请稍后再试。
文章 1–20